Propeller Health is a precision digital health company founded in 2007, headquartered in the United States, and recently received a Corporate Round investment from McKesson Ventures in 11 June 2018. The company's slogan, "Uplifting every person living with chronic disease so they can take control of their health and live a better life," reflects its mission to empower individuals with chronic diseases.
Propeller Health's offering, the Propeller Platform, comprises FDA-cleared and CE-marked medical devices, consumer apps, support and coaching, and secure access to clinical data for provider monitoring. This precision approach aims to motivate behavior change, track patient adherence, enable medication optimization, and predict costly exacerbations, thereby improving quality of life and clinical outcomes while lowering healthcare costs.
As a wholly owned subsidiary of ResMed, Propeller brings broad respiratory care expertise, digital therapeutic coverage, and global scale to its innovative approach in chronic respiratory care, as evidenced by more than 150 peer-reviewed abstracts and publications showcasing its efficacy.
Overall, Propeller Health is poised to make significant strides in the Health Care industry, with its comprehensive and impactful digital health solutions.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Corporate Round | Unknown | 1 | 11 Jun 2018 | |
Series D | $20.00M | 6 | AptarGroup, 3M New Ventures | 30 May 2018 |
Series C | $21.50M | 5 | 3M New Ventures | 20 Oct 2016 |
Series B | $14.50M | 2 | 04 Sep 2014 | |
Series A | $5.00M | 1 | 05 Apr 2013 |
No recent news or press coverage available for Propeller Health.